The development of new medical products that are considered the highest priority for people in developing countries is highly concentrated – among five pharmaceutical...International
The fight against life-threatening infections suffered another blow when one of the world’s biggest drug makers waved the white flag. Business Day reports that...Weekly Roundup
Rival cancer cell therapies from Swiss drugmaker Novartis and US-based Gilead Sciences have won a key recommendation from a European Medicines Agency panel, likely...Weekly Roundup
Amgen Inc has won approval from the US Food and Drug Administration for the first drug in a new class designed to prevent migraine headaches in adults. Reuters Health...
April 25th, 2018The worldwide resurgence of malaria, which kills half a million people a year, has sparked philanthropists, business leaders and ministers from donor and...
Pharmaceutical sales within the age-related macular degeneration (AMD) markets were estimated to be $4.9bn across the seven major markets in 2016. This is expected to...International
Prices for the cancer drug lomustine have rocketed nearly 1,400% since 2013, putting a potentially life-saving treatment out of reach for patients suffering from brain...Neurology
A King’s College London study shows treatment with the drug erenumab cut the number of days with migraine symptoms for 50% of patients.
Across the UK, an estimated...Africa
Novartis has begun testing a new anti-malaria pill in Africa, advancing development of an alternative to its most effective treatment, which billionaire philanthropist...
July 19th, 2017A US Food and Drug Administration (FDA) panel has opened a new era in medicine, unanimously recommending that the agency approve the first-ever treatment that...
